Fresh analysis indicates that people who discontinue new slimming jabs like Mounjaro or Wegovy tend to recover lost weight far faster than those who end conventional lifestyle plans.
Findings released in a prominent medical journal shows that while overweight individuals frequently drop a large proportion of their body weight while undergoing treatment, the mass is regained at an average rate of 0.8 kg per month once they quit.
"Users buying such drugs must be cognizant of the danger of fast rebound weight gain when the medication ends," warns lead investigator Dr. Susan Jebb.
Such speed of recovery means a return to starting weight within about a year and a half.
Weighing Approaches
The study, which examined dozens of studies involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with older methods.
The team emphasize that individuals who lose weight through diet and exercise usually experience a more gradual weight regain—perhaps 0.1 kg a month—after stopping.
The Reason for the Fast Rebound
Experts suggest the way of the drugs accounts for the heightened regain.
The injections imitate a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Sustained high doses of GLP-1 levels several times higher than normal may cause the body to produce less of its endogenous hormone, and may also diminish sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this GLP-1 'fix' results in hunger is unsuppressed, making binge eating a significant risk."
An Ongoing Disease?
The NHS suggest the injections for people with weight-linked health risks, alongside prescribed lifestyle changes.
A number of clinicians say that, given the likelihood of relapse, the therapy might need to be life-long.
This view is reinforced by pharmaceutical companies, who note that the results "highlight the chronic character of excess weight," similar to managing conditions like diabetes.
User Experiences
Users who have stopped the medication describe a intense return of cravings.
"I experienced a switch that goes on and you become ravenous," recalled an individual.
This difficulty is compounded if individuals have not developed lasting dietary or behavioural modifications during therapy.
Significant Interest
Survey data indicate that millions of people in the UK have used weight-loss jabs in the last 12 months, with desire remaining high.
- Use is higher among women than men.
- The 40s and 50s age group shows the greatest level of interest.
- Many obtain the medications through private healthcare rather than public health services.
In conclusion, clinicians stress that while the jabs are effective tools for shedding pounds, they are not a magic cure and long-term success likely depends on ongoing lifestyle support.
